The month ahead: May’s remaining events
ASCO is fast approaching, but in the meantime Olema will have an important readout.
SABCS 2023 – SERDs square off in combinations
Arvinas’s SERD appears to edge out Olema’s, but what’s the best CDK4/6 inhibitor for a phase 3 combination?
